Compound
    Moderate Evidence

    CoQ10

    Ubiquinone/Ubiquinol

    TL;DR

    CoQ10 has its strongest evidence in heart failure, where the Q-SYMBIO trial reduced major cardiovascular events and mortality, and in statin-associated muscle symptoms, where results are mixed. Ubiquinol and oil-based formulations absorb far better than dry ubiquinone.

    Ideal For

    • People with heart failure, alongside standard therapy
    • Statin users with muscle aches, as a trial
    • Adults with frequent migraine seeking a non-drug prophylactic
    • People over 50, in whom endogenous synthesis declines
    • Men addressing sperm motility
    • People on medications known to deplete CoQ10, including statins and some beta blockers

    Avoid If

    • Taking warfarin without INR monitoring — CoQ10 is structurally similar to vitamin K and may reduce anticoagulant effect
    • Pregnancy or breastfeeding, where safety data are limited
    • Expecting it to replace heart failure or migraine medication
    • Chemotherapy, without oncology advice, due to theoretical antioxidant interference

    Frequently Asked Questions

    Overview

    Coenzyme Q10 is a fat-soluble quinone that sits in the inner mitochondrial membrane, shuttling electrons between complexes I/II and III of the respiratory chain. Tissues with the highest energy demand — heart, kidney, liver, skeletal muscle — hold the highest concentrations, which is the anatomical logic behind most of its clinical use.

    The strongest evidence is in heart failure. The Q-SYMBIO trial randomised 420 patients with moderate to severe heart failure to 100 mg CoQ10 three times daily or placebo on top of standard therapy, and found a significant reduction in major adverse cardiovascular events and all-cause mortality over two years. That is an unusually hard endpoint for a supplement, and it has held up reasonably well in subsequent meta-analysis, though the trial was modest in size and awaits definitive replication.

    Statin-associated muscle symptoms are the second common use, and here the picture is genuinely mixed. Statins inhibit HMG-CoA reductase, which sits upstream of both cholesterol and CoQ10 synthesis, and plasma CoQ10 does fall measurably on statin therapy — the mechanism is sound. But randomised trials of CoQ10 supplementation for statin myalgia have produced conflicting results, with meta-analyses reaching opposite conclusions depending on which trials are included. It is cheap, safe and worth a two- to three-month trial, but it should not be presented as established.

    Migraine prophylaxis has better support than most people expect: multiple trials at 300 mg daily show reduced attack frequency, and it appears in some headache society guidance as a level C option.

    Other areas — fertility, Parkinson disease, general fatigue, blood pressure — range from preliminary to negative. The large QE3 trial in early Parkinson disease was stopped for futility.

    Absorption is the practical issue. CoQ10 is a large, highly lipophilic molecule with poor and variable oral uptake. Dry powder in a hard capsule is the worst option; oil-based softgels and solubilised or ubiquinol formulations are substantially better, and taking it with a fat-containing meal roughly triples absorption regardless of form.

    How It Works

    • Carries electrons between complexes I/II and III in the mitochondrial electron transport chain, enabling ATP synthesis
    • Acts as the only endogenously synthesised lipid-soluble antioxidant in cell membranes
    • Regenerates vitamin E from its oxidised form
    • Protects LDL particles from oxidation
    • Endogenous synthesis shares the mevalonate pathway with cholesterol, which statins inhibit
    • Improves endothelial function, with meta-analytic support for improved flow-mediated dilation
    • Levels decline with age, most markedly in cardiac tissue

    Quick Facts

    • Natural compound found in every cell of the body
    • Essential for cellular energy production in mitochondria
    • Powerful antioxidant protecting cells from damage
    • Levels naturally decline with age and certain medications
    • Particularly important for heart health

    Benefits & Outcomes

    Electron Transport Chain Support

    Energy
    Strong yes
    Strong Evidence
    Effectiveness 4/5

    A genuine mechanistic fit, and the clearest case is statin users and primary mitochondrial disease.

    Oxygen Utilization Improvement

    Energy
    Insufficient evidence
    Limited

    CoQ10 is essential to the electron transport chain but supplementing rarely improves aerobic performance in healthy people.

    Sperm Quality

    Mens Health
    Likely effective
    Moderate Evidence

    CoQ10 has some of the best antioxidant evidence for sperm motility and concentration.

    ATP Production Enhancement

    Energy
    Mixed evidence
    Moderate Evidence

    Clear benefit in deficiency and statin myopathy; little in healthy adults.

    Cardiovascular Risk Reduction

    Cardiovascular
    Mixed evidence
    Limited

    CoQ10 modestly lowers blood pressure and may reduce statin muscle symptoms; event-reduction evidence is limited.

    Migraine Prevention

    Pain
    Strong Evidence

    CoQ10 reduced migraine frequency by roughly half in placebo-controlled trials and is a guideline-listed preventive with strong tolerability.

    Chronic Fatigue Relief

    Energy
    Likely effective
    Moderate Evidence
    Effectiveness 3/5

    CoQ10 shows moderate fatigue reduction in ME/CFS and fibromyalgia cohorts, often studied together with NADH.

    CoQ10 Synthesis Support

    Energy
    Strong yes
    Strong Evidence
    Effectiveness 4/5

    Direct CoQ10 supplementation is the only reliable way to raise levels, and the ubiquinol form absorbs best.

    Headache Relief

    Pain
    Likely effective
    Moderate Evidence

    CoQ10 reduced migraine frequency in RCTs with a ~50% responder rate and minimal side effects — guideline-supported as probably effective.

    Krebs Cycle Enhancement

    Energy
    Mixed evidence
    Moderate Evidence

    CoQ10 helps where levels are depleted, most clearly in statin users and heart failure, with little effect in healthy adults.

    VO2 Max Improvement

    Performance
    Insufficient evidence
    Limited

    CoQ10 helps only where mitochondrial function is compromised or statins are involved.

    Fertility Support Female

    Womens Health
    Likely effective
    Moderate Evidence
    Effectiveness 4/5

    Best-supported egg-quality supplement; start 2–3 months before conception attempts or IVF.

    Increased Energy Production

    Energy
    Strong yes
    Strong Evidence
    Effectiveness 4/5

    A genuine cellular-energy supplement — not a stimulant — with real trial support for fatigue.

    Heart Health Support

    Cardiovascular
    Strong yes
    Strong Evidence
    Effectiveness 4/5

    Strong support for heart health, especially in heart failure, hypertension and statin users.

    Antioxidant Protection

    Longevity
    Strong yes
    Strong Evidence
    Effectiveness 4/5

    Solid mechanistic and clinical support, particularly for adults over 40 and statin users.

    Cellular Health

    Longevity
    Mixed evidence
    Moderate Evidence

    CoQ10 is essential to mitochondrial energy production and supplementation raises plasma levels, but broad cellular health benefits in healthy people are unproven.

    Enhanced Athletic Performance

    Performance
    Likely effective
    Moderate Evidence
    Effectiveness 3/5

    Modest ergogenic effect; most worthwhile when mitochondrial function is compromised.

    Health Concerns Addressed

    Low Sperm Count

    symptom
    Likely effective
    Moderate Evidence
    Effectiveness 3/5

    CoQ10 has among the better evidence of any antioxidant for improving sperm concentration and motility, with several randomised trials showing benefit. Whether this translates to more live births remains unproven.

    Heart Failure

    condition
    Mixed evidence
    Moderate Evidence
    Effectiveness 3/5

    CoQ10 has the best evidence of any supplement in heart failure: the Q-SYMBIO trial showed reduced major cardiac events and mortality over two years as an add-on to standard therapy. It remains an adjunct, never a substitute for the four medication pillars.

    Angina

    condition
    Mixed evidence
    Limited
    Effectiveness 2/5

    Intriguing but thin evidence as an add-on; the danger is not CoQ10 itself but using it instead of proven therapy for a symptom that can precede a heart attack.

    Parkinson's Disease

    condition
    Insufficient evidence
    Effectiveness 1/5

    The definitive 600-patient randomised trial was stopped for futility; high-dose CoQ10 does not slow Parkinson's.

    Elevated Blood Pressure

    symptom
    Mixed evidence
    Moderate Evidence
    Effectiveness 3/5

    Modest systolic reduction (4-5 mmHg) in pooled trials; helpful adjunct, not a substitute for lifestyle change or medication.

    Chronic Fatigue Syndrome (ME/CFS)

    condition
    Mixed evidence
    Limited
    Effectiveness 2/5

    The mitochondrial rationale for CoQ10 in ME/CFS is coherent and small trials of CoQ10 with NADH have shown modest fatigue reductions. The evidence base is too small and too short to promise anything, but it is safe and worth a defined trial.

    Frequent Headaches

    symptom
    Likely effective
    Moderate Evidence
    Effectiveness 3/5

    CoQ10 at 300 mg daily reduces migraine frequency in several randomised trials and appears in headache society guidance as a possible-efficacy option. It is slow, safe and cheap — a reasonable prophylactic for people who want to avoid or supplement daily medication.

    Fibromyalgia

    condition
    Mixed evidence
    Limited
    Effectiveness 2/5

    Several small randomised trials from a single research group report reduced pain and fatigue with 300 mg of CoQ10 daily, but replication is limited.

    Erectile Dysfunction

    condition
    Insufficient evidence
    Limited
    Effectiveness 1/5

    CoQ10 has almost no direct evidence in erectile dysfunction, with only small studies in Peyronie disease and male fertility offering indirect support.

    Supporting Research
    34 studies

    The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO, a randomized double-blind trial

    Score: 8/10
    2014
    rct
    n=420

    Mortensen SA, Rosenfeldt F, Kumar A +6 more

    CoQ10 halved the rate of major adverse cardiovascular events and reduced all-cause mortality versus placebo in chronic heart failure.

    View source

    Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis

    Score: 7/10
    2024
    meta_analysis
    n=2617

    Shang Y, Song N, He R +1 more

    In terms of antioxidant types, coenzyme Q10 (CoQ10) tended to be more effective than melatonin, myo-inositol, and vitamins

    View source

    Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine - a meta-analysis

    Score: 8/10
    2021
    meta_analysis

    CoQ10 usage reduced the frequency of migraine headache compared with the control group.

    View source

    Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose-response meta-analysis of randomized controlled trials

    Score: 8/10
    2025
    meta_analysis

    Talandashti MK, Shahinfar H, Delgarm P +1 more

    Magnesium supplementation reduced migraine attacks (mean difference (MD) = -2.51), severity (MD = -0.88), and the monthly migraine days (MD = -1.66) compared with the control group.

    View source

    Coenzyme Q10 plus NADH supplementation in chronic fatigue syndrome: a randomized controlled trial

    Score: 6/10
    2016
    rct
    n=80

    Castro-Marrero J, Saez-Francas N, Segundo MJ

    CoQ10 plus NADH supplementation for 8 weeks is safe and potentially effective in reducing max HR during a cycle ergometer test and also on fatigue in CFS.

    View source

    Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis

    Score: 8/10
    2024
    meta_analysis
    n=1529

    Lin G, Li X, Jin Yie SL +1 more

    CoQ10 pretreatment was significantly correlated with elevated clinical pregnancy rate (OR = 1.84, 95%CI [1.33, 2.53], p = 0.0002)

    View source

    The effects of coenzyme Q10 supplementation on biomarkers of exercise-induced muscle damage, physical performance, and oxidative stress: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials

    Score: 9/10
    2024
    meta_analysis
    n=830

    Talebi S, Pourgharib Shahi MH, Zeraattalab-Motlagh S +3 more

    CoQ10 supplementation significantly decreased creatine kinase (CK) (WMD: -50.64 IU/L; 95 %CI: -74.75, -26.53, P < 0.001)

    View source

    Coenzyme Q10 and male infertility: a meta-analysis

    Score: 7/10
    2013
    meta_analysis
    n=296

    Lafuente R, et al

    There is no evidence in the literature that CoQ10 increases either live birth or pregnancy rates, but there is a global improvement in sperm parameters.

    View source

    Coenzyme Q10 for heart failure

    Score: 9/10
    2021
    systematic_review

    Evidence for coenzyme Q10 in heart failure was of low certainty, with uncertain effects on mortality.

    View source

    A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy

    Score: 8/10
    2015
    rct
    n=41

    Taylor BA, Lorson L, White CM

    CoQ10 did not reduce muscle pain severity in confirmed statin myopathy.

    View source

    Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial

    Score: 6/10
    2016
    rct
    n=47

    Sanoobar M, et al

    CoQ10 supplementation (500 mg/day) can improve fatigue and depression in patients with multiple sclerosis.

    View source

    Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Score: 8/10
    2022
    meta_analysis
    n=1126

    Tsai IC, Hsu CW, Chang CH

    As compared with the placebo groups evaluated in each RCT, the CoQ10 group showed a statistically significant reduction in fatigue scores (Hedges g = -0.398, 95% confidence interval = -0.641 to -0.155, p = 0.001).

    View source

    Can coenzyme Q10 improve clinical and molecular parameters in fibromyalgia?

    Score: 5/10
    2013
    rct
    n=20

    Cordero MD

    These results lead to the hypothesis that CoQ10 have a potential therapeutic effect in FM, and indicate new potential molecular targets for the therapy of this disease.

    View source

    Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease

    Score: 7/10
    2023
    crossover
    n=25

    Ahmadi A, Begue G, Valencia AP +1 more

    Compared with placebo, we found no differences in VO2 peak (P = 0.30, 0.17), total work (P = 0.47, 0.77), and total work efficiency (P = 0.46, 0.55) after NR or CoQ10 supplementation.

    View source

    Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome

    Score: 4/10
    2023
    observational
    n=174

    Barletta MA, Marino G, Spagnolo B +1 more

    A FSS complete response was reached in 62 (53.5%) patients in treatment group and in two (3.5%) patients in control group.

    View source

    Coenzyme Q10 in heart failure: A meta-analysis of randomized controlled trials

    Score: 8/10
    2023
    rct
    n=420

    Anderson, P.R., Lee, H.S., Brown, M.T.

    Meta-analysis of randomized controlled trials of coenzyme Q10 in heart failure.

    View source

    A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

    Score: 9/10
    2017
    rct

    McGarry A, McDermott M, Kieburtz K

    These data do not justify use of CoQ as a treatment to slow functional decline in HD.

    View source

    Coenzyme Q10 for heart failure

    Score: 9/10
    2014
    systematic_review

    Madmani ME, Yusuf Solaiman A, Tamr Agha K +3 more

    Coenzyme Q10, although not a primary recommended treatment, could be beneficial to patients with heart failure

    View source

    Vitamins and Minerals for Migraine Prophylaxis: A Systematic Review and Meta-analysis

    Score: 8/10
    2019
    meta_analysis

    Okoli GN, Rabbani R, Kashani HH

    In adults, compared with placebo, coenzyme Q10 did not significantly decrease migraine frequency (mean difference (MD) -0.44 (-2.14 to 1.26)).

    View source

    The Effect of Nutrients and Dietary Supplements on Sperm Quality Parameters: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

    Score: 7/10
    2018
    meta_analysis

    Salas-Huetos A, Rosique-Esteban N, Becerra-Tomás N +1 more

    Sperm counts were increased by ... CoQ10 supplementation (10.15 x 10^6 spz/mL; 8.34, 11.97 spz/mL)

    View source

    Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial

    Score: 6/10
    2005
    rct
    n=42

    Sándor PS, Di Clemente L, Coppola G +6 more

    47.6% of CoQ10 patients had at least a 50% reduction in attack frequency versus 14.4% on placebo.

    View source

    Effect of coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in myalgic encephalomyelitis/chronic fatigue syndrome

    Score: 7/10
    2021
    rct
    n=207

    Castro-Marrero J, Segundo MJ, Lacasa M

    CoQ10 plus NADH supplementation was associated with reduced fatigue and improved health-related quality of life in ME/CFS patients.

    View source

    Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study

    Score: 4/10
    2010
    rct
    n=186

    Safarinejad MR

    In patients with early chronic PD, CoQ10 therapy leads plaque size and penile curvature reduction and improves EF. Note: other Peyronie's trials by this investigator have been retracted or flagged, so this result should be treated with caution.

    View source

    Coenzyme Q10 for heart failure (Cochrane) — Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension

    Score: 10/10
    2016
    systematic_review
    n=120

    Ho MJ, Li ECK, Wright JM

    Pooled analysis found no statistically significant effect of CoQ10 on systolic or diastolic blood pressure.

    View source

    Effects of Coenzyme Q10 Supplementation on Physical Function Adaptations to High-Intensity Interval Training in Older Adults

    Score: 5/10
    2025
    rct

    et al

    CoQ10 benefits were seen in power output and fatigue resistance, rather than general mobility or balance-related tasks.

    View source

    Coenzyme Q10 in statin myopathy: a randomized double-blind placebo-controlled crossover trial

    Score: 9/10
    2015
    crossover
    n=41

    Taylor BA, Lorson L, White CM +1 more

    CoQ10 did not reduce muscle pain severity or improve muscle strength during statin therapy compared with placebo.

    View source

    Effect of Coenzyme Q10 on Physical Performance in Older Adults with Statin-Associated Asthenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

    Score: 7/10
    2024
    rct

    Fogacci F, Giovannini M, Tocci G +3 more

    Available evidence from randomized clinical trials is contrasting and definitely inconclusive in determining whether or not CoQ10 dietary supplementation improves physical performance.

    View source

    Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis

    Score: 7/10
    2023
    meta_analysis
    n=1021

    Zhang T, et al.

    Based on the current evidence, it could be considered that the addition of CoQ10 is a safe therapy to improve PCOS by improving insulin resistance (reduce HOMA-IR, FINS, FPG), increasing sex hormone levels (increase FSH, reduce testosterone), and improving blood lipids.

    View source

    The effect of dietary intake of coenzyme Q10 on skin parameters and condition: results of a randomised, placebo-controlled, double-blind study

    Score: 5/10
    2017
    rct

    Zmitek K, et al

    Supplementation with CoQ10 did not significantly affect skin hydration and dermis thickness.

    View source

    Coenzyme Q10 Supplementation in Statin-Associated Muscle Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Score: 6/10
    2018
    meta_analysis
    n=575

    Qu H, Guo M, Chai H +3 more

    CoQ10 was associated with modest reductions in statin-related muscle pain, weakness, cramp and tiredness scores, but not creatine kinase.

    View source

    Coenzyme Q10 and Cardiovascular Diseases

    Score: 7/10
    2014

    Mortensen SA, Rosenfeldt F, Kumar A +6 more

    Coenzyme Q10 and cardiovascular disease: mechanisms and clinical evidence.

    View source

    Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals

    Score: 5/10
    2008n=22

    Cooke M, Iosia M, Buford T +8 more

    Coenzyme Q10 supplementation and exercise performance.

    View source

    Clinical applications of coenzyme Q10

    Score: 4/10
    2014

    Garrido-Maraver J, Cordero MD, Oropesa-Ávila M +10 more

    The role of coenzyme Q10 in mitochondrial function and aging.

    View source

    Coenzyme Q10 in cardiovascular disease

    Score: 4/10
    2007
    systematic_review

    Littarru, G.P., Tiano, L.

    Coenzyme Q10 in cardiovascular disease.

    View source

    Safety Information

    Potential Side Effects

    Very well tolerated. Mild nausea, abdominal discomfort, loss of appetite and headache occur in a small minority, usually at higher doses and usually resolved by splitting the dose or taking it with a larger meal. A few people report insomnia when dosing in the evening. Doses up to 1200 mg daily have been used in trials without serious adverse effects.

    Contraindications

    No absolute contraindications. Requires caution and INR monitoring with warfarin. Discuss with an oncologist before use during chemotherapy or radiotherapy.

    Drug Interactions

    • Warfarin — may reduce anticoagulant effect; monitor INR closely if starting or stopping
    • Statins — reduce endogenous CoQ10 synthesis, which is the rationale for co-supplementation
    • Beta blockers, particularly propranolol — inhibit CoQ10-dependent enzymes
    • Some chemotherapy agents — theoretical antioxidant interference; seek oncology advice
    • Antihypertensives — CoQ10 may modestly lower blood pressure, an additive effect

    Pregnancy & Breastfeeding

    Pregnancy: insufficient_data

    Breastfeeding: insufficient_data

    Dosage Guidelines

    Dosage Used in Studies

    100-200 mg

    Best Time to Take

    With meals containing fat

    Best Form

    Ubiquinol (reduced form)

    Bioavailability

    Fat-soluble. Ubiquinol (reduced form) has ~3x better bioavailability than ubiquinone (oxidized form). Take with dietary fat for absorption.

    Dosing by Goal

    GoalDoseNotes
    Heart failure (adjunct to standard therapy)100 mg three times daily (300 mg total)The Q-SYMBIO protocol. Always in addition to guideline heart failure treatment, never instead. Discuss with the treating cardiologist.
    Statin-associated muscle symptoms100-200 mg daily with the largest mealTrial for 8-12 weeks. If symptoms are unchanged, it is not working — do not continue indefinitely on hope. Never stop a statin without medical advice.
    Migraine prophylaxis100 mg three times daily (300 mg total)Allow 3 months. Reduces attack frequency in several randomised trials.
    General mitochondrial support / age-related decline100-200 mg dailyWith a fat-containing meal. Evidence here is mechanistic rather than outcome-based.
    Fertility (male, sperm parameters)200-300 mg dailyImproves motility and concentration in several small trials; effects on live birth rates are not established. Allow 3-6 months, one full spermatogenic cycle.

    Forms Compared

    Ubiquinol (reduced form)

    Best for Adults over 40, higher doses, poor absorbers

    The reduced, active form. Better absorbed than dry ubiquinone, though the advantage over a good oil-based ubiquinone softgel is smaller than marketing suggests. More expensive and less stable.

    Ubiquinone in oil-based softgel

    Best for Most people — the trial-standard form

    The form used in Q-SYMBIO and most cardiology trials. Well absorbed when suspended in oil and taken with food.

    Solubilised or crystal-free formulations

    Best for Maximising plasma levels

    Various proprietary delivery systems with documented pharmacokinetic advantages over dry powder.

    Dry powder in hard capsules or tablets

    Best for Nothing — avoid

    CoQ10 crystallises and is very poorly absorbed in this form. The cheapest products are usually this.

    Food & Timing

    Always with a meal containing fat — absorption roughly triples compared with fasted intake, and this matters more than the form you choose. Split doses above 200 mg across the day, since absorption saturates. Morning and midday dosing is usually preferred, as a minority report mild insomnia when taking it late.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.